Literature DB >> 21046555

RAE-1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres.

Natalia Popa1, Oriane Cedile, Xavier Pollet-Villard, Claude Bagnis, Pascale Durbec, José Boucraut.   

Abstract

Improving and controlling the capacity of endogenous or grafted adult neural stem cells to repair the nervous system relies on a better knowledge of interactions between immune cells and neural stem cells. Class I major histocompatibility complex (MHC) family members comprise numerous proteins playing either immune or nonimmune function. Among the latter, MHC functions in the central nervous system has started to receive recent interest. Here, our first goal was to investigate the potential relationship between MHC class I molecules and neurogenesis. For the first time, we report the expression of two MHC class I-related members by neural stem/progenitor cells: retinoic acid early induced transcript (RAE)-1 and CD1d. The expression of RAE-1 but not CD1d disappears when differentiation of neurosphere cells is induced. Interestingly, RAE-1 transcripts are expressed in the brain during development, and we demonstrate they persist in one of the main area of adult neurogenesis, the subventricular zone (SVZ). So far, RAE-1 is only known for its immune functions as a ligand of the activating receptor NKG2D expressed by natural killer (NK) cells, natural killer T, Tγδ, and some T CD8 lymphocytes. Here, we do not detect any NKG2D expression in the SVZ either in physiological or in pathological conditions. Interestingly, inhibition of RAE-1 expression in neurosphere cells reduces cell proliferation without alteration of cell viability, which argues for a nonimmune role for RAE-1. These results reveal an unexpected role of RAE-1 in regulating adult SVZ neurogenesis by supporting stem/progenitor cells proliferation.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21046555     DOI: 10.1002/glia.21074

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

1.  Ectopic expression of the immune adaptor protein CD3zeta in neural stem/progenitor cells disrupts cell-fate specification.

Authors:  Julie Angibaud; Stéphane J Baudouin; Antoine Louveau; Véronique Nerrière-Daguin; Virginie Bonnamain; Zsolt Csaba; Pascal Dournaud; Philippe Naveilhan; Nelly Noraz; Véronique Pellier-Monnin; Hélène Boudin
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

Review 2.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  The expression pattern of classical MHC class I molecules in the development of mouse central nervous system.

Authors:  Jiane Liu; Yuqing Shen; Mingli Li; Qian Shi; Aifeng Zhang; Fengqin Miao; Junhua Liu; Xiaojing Wu; Youji He; Jianqiong Zhang
Journal:  Neurochem Res       Date:  2012-11-17       Impact factor: 3.996

4.  T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.

Authors:  Heather VanSeggelen; Joanne A Hammill; Anna Dvorkin-Gheva; Daniela G M Tantalo; Jacek M Kwiecien; Galina F Denisova; Brian Rabinovich; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2015-06-30       Impact factor: 11.454

5.  M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.

Authors:  Alexandra Pisklakova; Brienne McKenzie; Franz Zemp; Xueqing Lun; Rajappa S Kenchappa; Arnold B Etame; Masmudur M Rahman; Karlyne Reilly; Shari Pilon-Thomas; Grant McFadden; Ebba Kurz; Peter A Forsyth
Journal:  Neuro Oncol       Date:  2016-03-08       Impact factor: 12.300

Review 6.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

7.  The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.

Authors:  Oriane Cédile; Natalia Popa; Frédéric Pollet-Villard; Nicolas Garmy; El Chérif Ibrahim; José Boucraut
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

8.  Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Authors:  Jason G Weinger; Warren C Plaisted; Sonia M Maciejewski; Lewis L Lanier; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

9.  Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts.

Authors:  Lori K Phillips; Elizabeth A Gould; Harish Babu; Sheri M Krams; Theo D Palmer; Olivia M Martinez
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

10.  Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.

Authors:  José M Rodríguez; Susanne Wolfrum; Megan Robblee; Kwan Y Chen; Zachary N Gilbert; Jae-Hoon Choi; Daniel Teupser; Jan L Breslow
Journal:  Circ Res       Date:  2013-08-15       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.